title: IMMUNOTHERAPY. Could microbial therapy boost cancer immunotherapy?
authors.affiliation: Department of Medicine, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY, USA.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Snyder
authors.affiliation: Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Lucille Castori Center for Microbes, Inflammation, and Cancer, New York, NY, USA.
authors.forename: Eric
authors.initials: E
authors.lastname: Pamer
authors.affiliation: Swim across America-Ludwig Collaborative Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Immunology Program, Ludwig Center for Cancer Immunotherapy, New York, NY, USA. wolchokj@mskcc.org.
authors.forename: Jedd
authors.initials: J
authors.lastname: Wolchok
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D060890:B7-H1 Antigen / Q000276:immunology*; D001439:Bacteroides / Q000276:immunology*; D001644:Bifidobacterium / Q000276:immunology*; D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors*; D005260:Female; D000069196:Gastrointestinal Microbiome / Q000276:immunology*; D006801:Humans; D008297:Male; D008545:Melanoma / Q000276:immunology* / Q000628:therapy*; D012878:Skin Neoplasms / Q000276:immunology* / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D060890:B7-H1 Antigen; D060908:CTLA-4 Antigen